These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 15042010

  • 1. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris LE, Einarson TR, Seaward PG, Ryan G, Willan AR, Windrim R.
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [Abstract] [Full Text] [Related]

  • 2. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS, Savage K, Lincoln T, Owen J.
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [Abstract] [Full Text] [Related]

  • 3. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
    Kapp N, Todd CS, Yadgarova KT, Alibayeva G, Nazarova D, Loza O, Babadjanova GS.
    Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
    [Abstract] [Full Text] [Related]

  • 4. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S, Fekih M, Chaïeb A, Bibi M, Mellouli R, Khaïri H.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [Abstract] [Full Text] [Related]

  • 5. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study.
    Ghorab MN, El Helw BA.
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):429-32. PubMed ID: 9598952
    [Abstract] [Full Text] [Related]

  • 6. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y, Chanrachakul B, Punyavachira P.
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [Abstract] [Full Text] [Related]

  • 7. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [Abstract] [Full Text] [Related]

  • 8. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
    Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW.
    Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
    [Abstract] [Full Text] [Related]

  • 9. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy.
    Su LL, Biswas A, Choolani M, Kalaichelvan V, Singh K.
    Am J Obstet Gynecol; 2005 Oct; 193(4):1410-4. PubMed ID: 16202734
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
    Dickinson JE, Godfrey M, Evans SF.
    J Matern Fetal Med; 1998 Oct; 7(3):115-9. PubMed ID: 9642607
    [Abstract] [Full Text] [Related]

  • 11. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL, Torres MA, Reyes R, Ortega L, García-Gallego F, Sánchez C.
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [Abstract] [Full Text] [Related]

  • 12. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS, Qvigstad E, Nesheim BI.
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [Abstract] [Full Text] [Related]

  • 13. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS, Lau WN, Chan CC, Ho PC.
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [Abstract] [Full Text] [Related]

  • 14. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
    Caliskan E, Filiz T, Yucesoy G, Coskun E, Vural B, Corakci A.
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
    [Abstract] [Full Text] [Related]

  • 15. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J, Chien PF, Thomson MA, Kosseim ML.
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [Abstract] [Full Text] [Related]

  • 16. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol.
    Colón I, Clawson K, Hunter K, Druzin ML, Taslimi MM.
    Am J Obstet Gynecol; 2005 Mar; 192(3):747-52. PubMed ID: 15746667
    [Abstract] [Full Text] [Related]

  • 17. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N, Russameecharoen K, Borriboonhirunsarn D.
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [Abstract] [Full Text] [Related]

  • 18. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C, Provensal M, Porcu G, Guidicelli B, Heckenroth H, Gamerre M, Bretelle F.
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [Abstract] [Full Text] [Related]

  • 19. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK, Mukherji J, Kamilya GS, Ray S, Hazra A.
    Acta Obstet Gynecol Scand; 2006 Mar; 85(12):1458-62. PubMed ID: 17260222
    [Abstract] [Full Text] [Related]

  • 20. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT, Papatsonis DN, Heydanus R.
    Ned Tijdschr Geneeskd; 2007 Apr 07; 151(14):815-20. PubMed ID: 17469323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.